Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Bovis Homes Share News (BVS)
BVS Share
Price
BVS Share
News
BVS Share
Chat
BVS Share
Trades
BVS
Live RNS
BVS Share
Charts
BVS Broker
Ratings
BVS Directors
Deals
BVS Financial
Diary
BVS
Fundamentals
BVS Short
Positions
BVS
Media
BVS Company
Research
BVS Company
Timeline
- There is currently no data for BVS
Friday broker round-up
IMI: Berenberg initiates at sell with a target price of 875p.
InterContinental Hotels: JP Morgan downgrades to underweight with a target price of 4,700p.
Rio Tinto: JP Morgan reiterates overweight with a target price of 5,500p.
Bovis Homes: Citigroup reiterates neutral with a target price of 1,081p.
Morrisons: Citigroup reiterates neutral with a target price of 205p.
AstraZeneca: Barclays reiterates overweight with a target price of 8,200p.
Petra Diamonds: JP Morgan reiterates neutral with a target price of 25p.
Latest BVS News
- Bovis Homes Plans Name Change To Vistry Group After Galliford Deal
3 Jan 2020 - Bovis and Galliford Try make management changes as acquisition completes
3 Jan 2020 - Galliford And Bovis GBP1.14 Billion Housebuilding Deal Edges Closer
2 Jan 2020 - UK WINNERS & LOSERS SUMMARY: Bodycote Rises After Ellison Acquisition
24 Dec 2019 - UK WINNERS & LOSERS SUMMARY: Domestic Sectors Surge After Tory Win
13 Dec 2019 - UK BROKER RATINGS SUMMARY: Goldman Sachs Double Upgrades M&S
9 Dec 2019 - LONDON BRIEFING: All Change At Tullow Oil And Amigo Holdings
9 Dec 2019 - Wednesday broker round-up
4 Dec 2019
Related News
WINNERS & LOSERS: Cizzle secures approval; MediaZest upbeat on outlook
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday.
EARNINGS AND TRADING: CleanTech loss narrows; Tap Global update
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:
AstraZeneca's Ultomiris wins US FDA priority review in kidney disease
(Alliance News) - AstraZeneca PLC on Monday said the US Food & Drug Administration has accepted and granted priority review to a supplemental biologic...
Bovis Homes News
Bovis Homes Plans Name Change To Vistry Group After Galliford Deal
Bovis Homes Plans Name Change To Vistry Group After Galliford Deal
Bovis and Galliford Try make management changes as acquisition completes
(Sharecast News) - Bovis Homes Group has completed the acquisition of Galliford Try's Linden Homes and Partnerships & Regeneration businesses, it ...
Galliford And Bovis GBP1.14 Billion Housebuilding Deal Edges Closer
Galliford And Bovis GBP1.14 Billion Housebuilding Deal Edges Closer
UK WINNERS & LOSERS SUMMARY: Bodycote Rises After Ellison Acquisition
UK WINNERS & LOSERS SUMMARY: Bodycote Rises After Ellison Acquisition
UK WINNERS & LOSERS SUMMARY: Domestic Sectors Surge After Tory Win
UK WINNERS & LOSERS SUMMARY: Domestic Sectors Surge After Tory Win
UK BROKER RATINGS SUMMARY: Goldman Sachs Double Upgrades M&S
UK BROKER RATINGS SUMMARY: Goldman Sachs Double Upgrades M&S
LONDON BRIEFING: All Change At Tullow Oil And Amigo Holdings
LONDON BRIEFING: All Change At Tullow Oil And Amigo Holdings
Wednesday broker round-up
(Sharecast News) - Moneysupermarket: RBC Capital Markets downgrades to underperform with a target price of 300p.
Follow the stocks
